Medtronic (MDT) Issues Positive Update on TAVR Using CoreValve System vs. SAVR in High-Risk Stenosis Patients
Tweet Send to a Friend
Medtronic (NYSE: MDT) revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
